Endocyte (ECYT - Get Report) is a biopharmaceutical company. Endocyte is engaged in developing therapies for the treatment of cancer and inflammatory diseases. This stock is trading up 7.6% to $8.20 in recent trading.
Today's Range: $7.85-$8.5752-Week Range: $3.02-$14.80 Volume: 5.1 million Three-Month Average Volume: 970,978 >>7 Hot Stocks on Traders' Radars From a technical perspective, ECYT is continuing to move higher today after the stock just gapped up huge yesterday from under $4 to $7.50 on monster volume. This move today is pushing the stock back above its 200-day moving average of $7.99 with heavy volume. Traders should now look for long biased trades as long as ECYT is trending above its 200-day, and if it can manage to close near its daily highs today. If we continue to see ECYT trending above its 200-day, then this stock could easily tag its December high of $11.11 soon. That said, any high-volume drop back below its 200-day, and below its gap-day high low of $7.23 could put this stock in danger to fill some of that massive gap to the downside.